These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12722221)

  • 1. [Hepatitis C].
    Yano K; Yatsuhashi H; Yano M
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():241-4. PubMed ID: 12722221
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of hepatitis C virus RNA].
    Ohishi W; Chayama K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):214-8. PubMed ID: 15359795
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of patients with hepatitis C virus infection. Virological tests].
    Pawlotsky JM
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B180-7. PubMed ID: 12180286
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 5. HCV genotype 5: epidemiology and spread of an uncommon genotype.
    Verbeeck J; Peigue-Lafeuille H; Ross RS; Abergel A; Nevens F; Van der Merwe S; Van Ranst M; Henquell C
    J Clin Virol; 2008 Feb; 41(2):170-1. PubMed ID: 18069057
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical, virologic and pathologic features of asymptomatic hepatitis C virus carriers].
    Shindo M; Okuno T
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):376-80. PubMed ID: 15359825
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hepatitis C after liver transplantation].
    Samuel D; Roche B; Feray C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B231-7. PubMed ID: 12180295
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin: Reappearance of references published in 2005-2009.
    Gelderblom HC; Beld MG
    J Clin Virol; 2010 Jun; 48(2):150-1; author reply 152. PubMed ID: 20347385
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis C virus infection--after 20 years].
    Pár A
    Orv Hetil; 2010 Mar; 151(12):485-93. PubMed ID: 20231132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

  • 14. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C in childhood--natural history and therapy].
    Nagata I; Murakami J; Okamoto M; Iitsuka T; Kanzaki S; Shiraki K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):634-9. PubMed ID: 15359875
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current and future applications of viral clearance kinetics in the treatment of hepatitis C].
    Buti M
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():24-9. PubMed ID: 15195531
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis C virus infection].
    Nakagawa M; Enomoto N; Sakamoto N
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():627-33. PubMed ID: 12718039
    [No Abstract]   [Full Text] [Related]  

  • 18. Modelling how ribavirin improves interferon response rates in hepatitis C virus infection.
    Dixit NM; Layden-Almer JE; Layden TJ; Perelson AS
    Nature; 2004 Dec; 432(7019):922-4. PubMed ID: 15602565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C.
    Sauleda S; Esteban JI; Altisent C; Puig L; Esteban R; Guardia J
    Thromb Haemost; 2000 Jun; 83(6):807-10. PubMed ID: 10896229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection: an overview.
    Hwang SJ
    J Microbiol Immunol Infect; 2001 Dec; 34(4):227-34. PubMed ID: 11825001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.